Tonsillar lymphoma usually presents as unilateral or bilateral infiltration of diffuse large B-cell lymphomas. We report a case of a 79-year-old man with near-complete obstruction of the upper airways due to T-cell prolymphocytic leukemia cells.
A 79-year-old man was referred to our hospital because of persistent sore throat, dysphagia, and shortness of breath over the past two months. Physical examination of the oral cavity revealed bilateral tonsillar hypertrophy resulting in the nearcomplete obstruction of the upper airway ( Figure 1A ) and disseminated skin nodules ( Figure 1B) . A total-body computed tomography confirmed tonsillar enlargement ( Figure  1C ), and widespread lymphadenopathy both above and below the diaphragm. Cell blood count showed leukocytosis WBC 44.000/μL, and flow cytometric analysis of bone marrow cells ( Figure 1D ) identified an abnormal T-cell population expressing TCR α/β, CD2, CD3, CD4, CD5, CD7, and CD52. Cytogenetics confirmed a complex karyotype including an inversion of chromosome 14. These findings were indicative of T-cell prolymphocytic leukemia (T-PLL). Bone marrow biopsy ( Figure 1E ) and histological analysis of tonsillectomy specimen ( Figure 1F ) confirmed the T-PLL lymphoid infiltrate.
T-PLL is an aggressive cancer characterized by the hyperproliferation of post-thymic prolymphocytes. T-PLL accounts for ~2% of mature lymphocytic leukemias in adults. 1 The majority of patients present with nodal involvement (58%), and splenomegaly is among the most common physical finding (38%). 2 Skin lesions, including nodules, maculopapular rashes, or more rarely erythroderma, are described in ~20% of patients. 2 T-PLL is usually resistant to conventional chemotherapy, and complete remissions are rare including the one achieved with alemtuzumab-based regimens. 3 Because of patients' life-threatening condition, age, and severe risk of alemtuzumab infusion-associated reactions, we initially tried cytoreducing the disease with age-adjusted chemotherapy based on cyclophosphamide, vincristine, and high-dose prednisone followed by the administration of 400 mg venetoclax for a month. 4 However, after an initial response, we observed a worsening of clinical conditions that prompted surgical excision that improved the burden of the oral symptoms. While T-PLL cutaneous infiltration is frequently observed in this disease, this is the first report describing a bilateral tonsillar involvement. 
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